PharmAla-1
| APA-01 | |
|---|---|
| Molecular structure drawn from PubChem coordinates |
| Rotamer [] | |
|---|---|
| Conformer structure via 3Dmol.js |
| Physical properties [] | |
|---|---|
| Molecular mass | 205.25 g/mol [1] |
| Predicted LogP | 2.3 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C12H15NO2 |
| IUPAC name | (2R)-2-(1,3-benzodioxol-5-ylmethyl)pyrrolidine |
| SMILES | C1C[C@@H](NC1)CC2=CC3=C(C=C2)OCO3 |
| InChI | InChI=1S/C12H15NO2/c1-2-10(13-5-1)6-9-3-4-11-12(7-9)15-8-14-11/h3-4,7,10,13H,1-2,5-6,8H2/t10-/m1/s1 |
| InChIKey | IRWQJDYJIAIJSC-SNVBAGLBSA-N |
| PubChem CID | 94680847 |
PharmAla-1 (also known as Schembl27075574) is a substance of the 2-benzylpyrrolidine and 3,4-methylenedioxyphenethylamine class.
Chemistry
Stereochemistry []
PharmAla-1 is a single defined stereoisomer.
Druglikeness
Lipinski's rule of five
PharmAla-1 matches Lipinski's rule of five.External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 94680847, PharmAla-1. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/94680847
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 09:50:53 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 09:50:49 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 09:50:49 |
| gsrs | missing (no UNII) | 2026-11-20 09:50:49 |
| hmdb | missing (no HMDB id) | 2026-11-20 09:50:49 |
| kegg | missing (no KEGG DRUG entry) | 2026-11-20 09:50:51 |
| pubchem | ok | 2026-11-20 09:50:48 |
| missing (no r/tripreports posts mention it) | 2026-11-20 09:50:49 | |
| sider | missing (not in SIDER) | 2026-11-20 09:50:49 |
| structure | ok | 2026-11-20 09:50:49 |
| wikipedia | ok | 2026-11-20 09:50:49 |